Pathoquest has raised EUR 8 million from investiere, Kurma Partners, Idinvest Partners, and strategic investor Charles River Laboratories. investiere contributed EUR 0.7 million to this round. 

PathoQuest is a genomic expert company dedicated to the microbiology testing market and a leader in clinical diagnostics and biologics testing applications.

“We are excited to make this investment in PathoQuest since they represent an exciting healthcare company that delivers novel solutions addressing challenges faced by biopharmaceutical companies in their quest to deliver safer, better treatments to patients,” stated Chris Gay-Crosier, Head International Investments at investiere. Pathoquest is investiere’s second investment in France.

The funds raised will help Pathoquest accelerate its growth.